Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 3934435)

Published in J Asthma on November 04, 2013

Authors

David Price1, Peter Dale, Emma Elder, Kenneth R Chapman

Author Affiliations

1: Division of Applied Health Sciences, University of Aberdeen , Aberdeen , UK .

Articles cited by this

The global burden of asthma. Chest (2006) 5.74

Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol (2006) 4.80

Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61

Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest (1998) 2.62

Improved asthma outcomes in a high-morbidity pediatric population: results of an emergency department-based randomized clinical trial. Arch Pediatr Adolesc Med (2006) 1.90

Stress and inflammation in exacerbations of asthma. Brain Behav Immun (2007) 1.80

Achieving asthma control in practice: understanding the reasons for poor control. Respir Med (2008) 1.61

Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev (2012) 1.43

ALMA, a new tool for the management of asthma patients in clinical practice: development, validation and initial clinical findings. Prim Care Respir J (2012) 1.41

Gastroesophageal reflux: a potential asthma trigger. Immunol Allergy Clin North Am (2005) 1.25

Inhalation challenge effects of perfume scent strips in patients with asthma. Ann Allergy Asthma Immunol (1995) 1.07

What do we know about asthma triggers? a review of the literature. J Asthma (2012) 1.06

Ozone: a trigger for hospital pediatric asthma emergency room visits. Pediatr Pulmonol (2000) 1.01

Cough, airway inflammation, and mild asthma exacerbation. Arch Dis Child (2002) 0.98

Reliability and validity of the Asthma Trigger Inventory applied to a pediatric population. J Pediatr Psychol (2006) 0.97

Introduction of Asthma APGAR tools improve asthma management in primary care practices. J Asthma Allergy (2008) 0.96

Asthma exacerbations. 2: aetiology. Thorax (2006) 0.94

Medications as asthma triggers. Immunol Allergy Clin North Am (2005) 0.92

The asthma trigger inventory: validation of a questionnaire for perceived triggers of asthma. Psychosom Med (2006) 0.91

Laughter-associated asthma. J Asthma (2004) 0.91

Communication and education about triggers and environmental control strategies during pediatric asthma visits. Patient Educ Couns (2011) 0.90

Can subjective asthma symptoms be learned? Psychosom Med (2005) 0.89

Perceived triggers of asthma: evaluation of a German version of the Asthma Trigger Inventory. Respir Med (2007) 0.89

Trigger recognition and management in poorly controlled asthmatics. Allergy Asthma Proc (2010) 0.87

Triggers in adult asthma: are patients aware of triggers and doing right? Allergol Immunopathol (Madr) (2009) 0.86

The role of the primary care physician in helping adolescent and adult patients improve asthma control. Mayo Clin Proc (2011) 0.84

Exercise-induced asthma: a practical guide to definitions, diagnosis, prevalence, and treatment. Allergy Asthma Proc (1997) 0.83

History of symptom triggers in patients presenting to the emergency department for asthma. J Asthma (2012) 0.82

Patients' perceptions of food-induced asthma. Aust N Z J Med (1996) 0.81

Validation of a web-based version of the asthma control test and childhood asthma control test. Pediatr Pulmonol (2011) 0.80

Pets and smoking in the home associated with asthma symptoms and asthma-like breathing problems. Policy Brief UCLA Cent Health Policy Res (2007) 0.79

Articles by these authors

Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J (2006) 3.27

Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol (2003) 2.43

Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med (2014) 2.00

A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada. Environ Health Perspect (2009) 1.77

Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med (2006) 1.71

Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study. Chest (2010) 1.49

The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest (2006) 1.38

Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician (2007) 1.24

Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study. Respir Med (2013) 1.19

Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD. BMC Pulm Med (2013) 1.11

What do we know about asthma triggers? a review of the literature. J Asthma (2012) 1.06

Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD (2012) 1.04

Variations and gaps in management of acute asthma in Ontario emergency departments. Chest (2008) 0.97

The coming of age of asthma guidelines. Lancet (2008) 0.96

Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med (2002) 0.95

Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.89

Diffuse panbronchiolitis in a Caucasian man in Canada. Can Respir J (2003) 0.89

Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One (2013) 0.89

A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Anesthesiology (2012) 0.88

Profile of eicosanoids in breath condensate in asthma and COPD. J Breath Res (2012) 0.87

Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest (2003) 0.86

Women and asthma: lessons from a gender analysis of the asthma in Canada survey. J Asthma (2006) 0.85

Omalizumab for asthma: pharmacology and clinical profile. Expert Rev Respir Med (2009) 0.84

An electronic diary is shown to be more reliable than a paper diary: results from a randomized crossover study in patients with persistent asthma. J Asthma (2012) 0.84

Hot tub lung mimicking classic acute and chronic hypersensitivity pneumonitis: two case reports. Can Respir J (2007) 0.84

Influence of current or former smoking on asthma management and control. Can Respir J (2008) 0.83

Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome? Treat Respir Med (2005) 0.83

Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor. Eur Respir J (2012) 0.83

The value of early diagnosis for effective management of chronic obstructive pulmonary disease. J Fam Pract (2007) 0.82

Economic issues in the use of office spirometry for lung health assessment. Can Respir J (2003) 0.82

The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med (2008) 0.82

Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ (2012) 0.82

Dynamic airway evaluation with volume CT: initial experience. Can Assoc Radiol J (2010) 0.82

Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada. Curr Med Res Opin (2008) 0.81

Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol (2003) 0.81

Evaluation of a questionnaire to assess compliance with anti-asthma medications. J Asthma (2004) 0.81

Parent-reported symptoms may not be adequate to define asthma control in children. Pediatr Pulmonol (2007) 0.80

Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction. Int J Gen Med (2010) 0.79

Tiotropium and simplified detection of dynamic hyperinflation. Chest (2007) 0.79

Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario. Can Respir J (2011) 0.78

Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study. BMC Clin Pharmacol (2010) 0.78

Measurement properties of an asthma symptom and rescue medication use diary. J Asthma (2014) 0.77

SMART isn't. J Allergy Clin Immunol (2010) 0.76

Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma. Respir Med (2009) 0.76

Questioning the economic evaluation of omalizumab. J Allergy Clin Immunol (2008) 0.76

A step forward in COPD management: reading between the lines. Chest (2012) 0.75

Predicting the need for supplemental oxygen during airline flight in patients with chronic pulmonary disease: a comparison of predictive equations and altitude simulation. Can Respir J (2009) 0.75

Asthma controller delay and recurrence risk after an emergency department visit or hospitalization. Respir Med (2012) 0.75

Alpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and management. COPD (2015) 0.75

Seretide: a pharmacoeconomic analysis. J Med Econ (2008) 0.75

A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study. J Glaucoma (2017) 0.75